Related Experiment Video
Updated: Aug 24, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Case report of severe refractory inflammatory dermatoses in a young female diagnosed with hereditary alpha
Allison Kranyak1, Marshall Shuler1, Kelli W Williams2
1University of South Carolina School of Medicine Greenville, Greenville, South Carolina, USA.
Insights
Hereditary alpha tryptasemia (HaT) is linked to various health issues. This study highlights HaT in a child with severe skin and allergy symptoms, suggesting its role in refractory inflammatory dermatologic conditions.
Area of Science:
- Genetics and rare diseases
- Dermatology
- Allergology
Background:
- Hereditary alpha tryptasemia (HaT) is an autosomal dominant genetic disorder.
- HaT is associated with diverse systemic manifestations, including dermatologic, allergic, and gastrointestinal issues.
Observation:
- A pediatric case with treatment-resistant, mixed cutaneous inflammatory and atopic manifestations is presented.
- The patient was diagnosed with Hereditary alpha tryptasemia.
Findings:
- This case links Hereditary alpha tryptasemia to severe, refractory inflammatory dermatologic conditions.
- The findings suggest HaT as a potential underlying cause for unexplained inflammatory skin diseases.
Implications:
- Consider HaT in pediatric patients with refractory inflammatory dermatologic disease.
- Mast cell activation should be evaluated in individuals with suspected HaT and related symptoms.
- Early diagnosis of HaT can guide management of complex allergic and dermatologic conditions.
Abstract:
Hereditary alpha tryptasemia (HaT), an autosomal dominant condition first described in 2014, has previously been associated with multiple dermatologic, allergic, gastrointestinal, neuropsychiatric, autonomic, and connective tissue abnormalities. We describe a pediatric patient with predominantly mixed cutaneous inflammatory manifestations and atopic manifestations resistant to treatment who was found to have HaT. HaT should be considered in individuals with refractory inflammatory dermatologic disease and signs and/or symptoms concerning for mast cell activation.
Related Concept Videos
Pedigree Analysis
Inborn Errors of Metabolism
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

